Brivaracetam API

Name of Product	Brivaracetam
CAS No	357336-20-0
Therapeutic use:-	Racetam nootropic – cognitive enhancer; also used for myoclonus, vertigo, stroke-related deficits
Grade	EP/IP
Form:-	API Powder
Status	Commercial

Product Overview

Brivaracetam API is a third-generation AED, or antiepileptic medication.

It binds to the synaptic vesicle protein 2A (SV2A) in a selective and high-affinity way.

This process controls the release of neurotransmitters at synapses, which stabilizes neuronal excitability and lowers the number of seizures.

Brivaracetam API has 10–30x higher binding affinity for SV2A than Levetiracetam.

This means that it can control seizures well at lower doses and is easier to handle.

It is mostly used to treat partial-onset (focal) seizures in adults, teens, and kids.

It was created to stringent GMP standards.

You can use it in medicines like tablets, oral solutions, and shots.

Therapeutic Class: Antiepileptic / Anticonvulsant.

Approved as a single treatment or in addition to other treatments for partial-onset seizures in people who are at least 4 years old.
Being clinically evaluated for generalized epilepsy and other neurological disorders characterized by atypical brain activity.
Fewer behavioral side effects than levetiracetam.
Better cognitive tolerance, which makes it good for managing epilepsy over the long run.

For proper packaging and storage, we take all the required measures:

HDPE barrels or fiber containers that can hold from a small quantity to a large quantity.

We ensure to put two polyethylene bags into airtight containers to keep the material secure.

You can get custom packaging for R&D, pilot, and commercial scale if you ask.

Always a better choice to keep it in the fridge at 2°C to 8°C.

Put the container well closed and out of the sun, moisture, and heat.

Make sure that handling is done according to GMP and GDP rules.

Shelf life is from 24 to 36 months from the date of manufacture if stored correctly.

Manufacturing that follows GMP guidelines: Made according to WHO-GMP, EU-GMP, and cGMP rules, which ensures that it meets worldwide standards.
Regulatory Documentation: Full technical package available, including COA, MSDS, DMF (Type II on request), and stability data.
High Purity and Consistency: Advanced purification processes make sure that the assay is at least 99% and that there are very few residual solvents.
Global Supply Capability: A reliable partner for providing APIs to both regulated and semi-regulated markets. Extensive experience in global API exports.
Flexible Solutions: We may change the size of the batches, the packaging options, and the documentation assistance to meet the demands of each client.